Search Results - "Peters, Cole"

Refine Results
  1. 1

    Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models by Saha, Dipongkor, Wakimoto, Hiroaki, Peters, Cole W, Antoszczyk, Slawomir J, Rabkin, Samuel D, Martuza, Robert L

    Published in Clinical cancer research (15-07-2018)
    “…Glioblastoma (GBM), a fatal brain cancer, contains a subpopulation of GBM stem-like cells (GSCs) that contribute to resistance to current therapy. Angiogenesis…”
    Get full text
    Journal Article
  2. 2

    Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules by Peters, Cole W. D., Nigim, Fares

    “…The dogma of engineering oncolytic viral vectors has shifted from emphasizing the viral lysis of individual cancer cells to the recruitment and coordination of…”
    Get full text
    Journal Article
  3. 3

    Delivering AAV to the Central Nervous and Sensory Systems by Peters, Cole W., Maguire, Casey A., Hanlon, Killian S.

    “…As gene therapy enters mainstream medicine, it is more important than ever to have a grasp of exactly how to leverage it for maximum benefit. The development…”
    Get full text
    Journal Article
  4. 4

    Mini-PCDH15 gene therapy rescues hearing in a mouse model of Usher syndrome type 1F by Ivanchenko, Maryna V., Hathaway, Daniel M., Klein, Alex J., Pan, Bifeng, Strelkova, Olga, De-la-Torre, Pedro, Wu, Xudong, Peters, Cole W., Mulhall, Eric M., Booth, Kevin T., Goldstein, Corey, Brower, Joseph, Sotomayor, Marcos, Indzhykulian, Artur A., Corey, David P.

    Published in Nature communications (26-04-2023)
    “…Usher syndrome type 1 F (USH1F), caused by mutations in the protocadherin-15 gene ( PCDH15 ), is characterized by congenital deafness, lack of balance, and…”
    Get full text
    Journal Article
  5. 5

    Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F by Peters, Cole W., Hanlon, Killian S., Ivanchenko, Maryna V., Zinn, Eric, Linarte, Elizabeth F., Li, Yaqiao, Levy, Jonathan M., Liu, David R., Kleinstiver, Benjamin P., Indzhykulian, Artur A., Corey, David P.

    Published in Molecular therapy (02-08-2023)
    “…Usher syndrome type 1F (USH1F), characterized by congenital lack of hearing and balance and progressive loss of vision, is caused by mutations in the PCDH15…”
    Get full text
    Journal Article
  6. 6

    Designing herpes viruses as oncolytics by Peters, Cole, Rabkin, Samuel D

    Published in Molecular therapy. Oncolytics (2015)
    “…Oncolytic herpes simplex virus (oHSV) was one of the first genetically-engineered oncolytic viruses. Because HSV is a natural human pathogen that can cause…”
    Get full text
    Journal Article
  7. 7

    Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non‐human primate by Lei, Ji, Zhang, Alexander, Deng, Hongping, Yang, Zhihong, Peters, Cole W., Lee, Kang M., Wang, Zhenjuan, Rosales, Ivy A., Rickert, Charles G., Markmann, James F.

    Published in American journal of transplantation (01-03-2022)
    “…Clinical islet transplantation has relied almost exclusively on intraportal administration of pancreatic islets, as it has been the only consistent approach to…”
    Get full text
    Journal Article
  8. 8

    AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear by Ivanchenko, Maryna V., Hanlon, Killian S., Hathaway, Daniel M., Klein, Alex J., Peters, Cole W., Li, Yaqiao, Tamvakologos, Panos I., Nammour, Josette, Maguire, Casey A., Corey, David P.

    “…Gene therapy strategies using adeno-associated virus (AAV) vectors to treat hereditary deafnesses have shown remarkable efficacy in some mouse models of…”
    Get full text
    Journal Article
  9. 9

    Updates on Oncolytic Virus Immunotherapy for Cancers by Peters, Cole, Grandi, Paola, Nigim, Fares

    Published in Molecular therapy. Oncolytics (29-03-2019)
    “…The 2018 annual Cambridge Healthtech Institute’s International Immuno-Oncology Summit in Boston, MA convened late August, and academic and industry researchers…”
    Get full text
    Journal Article
  10. 10

    Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy by Tang, Jack Pengfei, Peters, Cole W, Quiros, Crystal, Wang, Xiaoyan, Klomhaus, Alexandra M, Yamada, Reiko E, Timmerman, John M, Moore, Theodore B, Nowicki, Theodore S

    Published in Cancer immunology research (02-12-2022)
    “…A major complication of chimeric antigen receptor (CAR) T-cell therapy is immune effector cell-associated neurotoxicity syndrome (ICANS), which presents as…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Construction of a Sonchus Yellow Net Virus Minireplicon: a Step toward Reverse Genetic Analysis of Plant Negative-Strand RNA Viruses by Ganesan, Uma, Bragg, Jennifer N, Deng, Min, Marr, Sharon, Lee, Mi Yeon, Qian, Shasha, Shi, Manling, Kappel, Justin, Peters, Cole, Lee, Yeon, Goodin, Michael M, Dietzgen, Ralf G, Li, Zhenghe, Jackson, Andrew O

    Published in Journal of Virology (01-10-2013)
    “…Erratum ( vol. 87 , p. 13081 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
    Get full text
    Journal Article
  15. 15

    PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1F Models by Ivanchenko, Maryna V, Hathaway, Daniel M, Mulhall, Eric M, Booth, Kevin Ta, Wang, Mantian, Peters, Cole W, Klein, Alex J, Chen, Xinlan, Li, Yaqiao, György, Bence, Corey, David P

    Published in The Journal of clinical investigation (15-10-2024)
    “…Usher syndrome type 1F (USH1F), resulting from mutations in the protocadherin-15 (PCDH15) gene, is characterized by congenital lack of hearing and balance, and…”
    Get full text
    Journal Article
  16. 16

    Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer by Bommareddy, Praveen K, Peters, Cole, Saha, Dipongkor, Rabkin, Samuel D, Kaufman, Howard L

    Published in Annual review of cancer biology (04-03-2018)
    “…Oncolytic viruses are native or modified viruses that directly kill tumor cells but spare normal tissue and promote host antitumor immunity. Recently, an…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics by Peters, Cole, Nigim, Fares, Chiocca, E Antonio, Rabkin, Samuel D

    Published in Molecular therapy. Oncolytics (08-06-2016)
    “…Boston, Massachusetts, was the site of the 9th International Conference on Oncolytic Virus Therapeutics held 13–16 June 2015. An overarching theme of the…”
    Get full text
    Journal Article
  19. 19

    Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma by Ning, Jianfang, Wakimoto, Hiroaki, Peters, Cole, Martuza, Robert L, Rabkin, Samuel D

    “…Clinical success of poly(ADP-ribose) polymerase inhibitors (PARP i ) has been limited to repair-deficient cancers and by resistance. Oncolytic herpes simplex…”
    Get full text
    Journal Article
  20. 20